Travere Therapeutics Inc — Balance Sheet (NASDAQ:TVTX) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics Dividends

Quarterly Annual

Total assets 607.44 M776.63 M672.59 M788.91 M594.13 M605.19 M Total liabilities 396.23 M474.52 M629.73 M588.1 M535.05 M490.36 M Total equity 211.21 M302.11 M42.85 M200.81 M59.08 M114.83 M Total liabilities & shareholders' equities 607.44 M776.63 M672.59 M788.91 M594.13 M605.19 M Total debt —————— Net debt ——————

뉴스

Ligand, 로열티 성장 힘입어 4분기 실적 기대치 상회

Travere Therapeutics: FILSPARI Drives Revenue, FSGS PDUFA Looms (NASDAQ:TVTX)

Travere Therapeutics, Inc. (TVTX) Q4 2025 Earnings Call Transcript

Travere Therapeutics (TVTX) Matches Q4 Earnings Estimates

Travere Therapeutics, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:TVTX) 2026-02-19

Travere Therapeutics posts surprise Q4 profit; Shares slip 5% on revenue miss

Travere Therapeutics earnings beat by $0.41, revenue fell short of estimates

트라베어 테라퓨틱스, FSGS 승인 지연 속 실적 시험대

Walmart, Southern Co, Newmont Mining and more set to report earnings Thursday

Kiniksa Pharmaceuticals International, plc (KNSA) Earnings Expected to Grow: Should You Buy?

Travere Therapeutics (TVTX) Earnings Expected to Grow: Should You Buy?

Travere Therapeutics, 전략적 방향에 자신감 표명